DNA Methylation in Genetic and Sporadic Forms of Neurodegeneration: Lessons from Alzheimer’s, Related Tauopathies and Genetic Tauopathies

Genetic and sporadic forms of tauopathies, the most prevalent of which is Alzheimer’s Disease, are a scourge of the aging society, and in the case of genetic forms, can also affect children and young adults. All tauopathies share ectopic expression, mislocalization, or aggregation of the microtubule...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Geraldine Zimmer-Bensch, Hans Zempel
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
TAU
Acceso en línea:https://doaj.org/article/d37cc600ad824f99af45406ab5a87325
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d37cc600ad824f99af45406ab5a87325
record_format dspace
spelling oai:doaj.org-article:d37cc600ad824f99af45406ab5a873252021-11-25T17:11:03ZDNA Methylation in Genetic and Sporadic Forms of Neurodegeneration: Lessons from Alzheimer’s, Related Tauopathies and Genetic Tauopathies10.3390/cells101130642073-4409https://doaj.org/article/d37cc600ad824f99af45406ab5a873252021-11-01T00:00:00Zhttps://www.mdpi.com/2073-4409/10/11/3064https://doaj.org/toc/2073-4409Genetic and sporadic forms of tauopathies, the most prevalent of which is Alzheimer’s Disease, are a scourge of the aging society, and in the case of genetic forms, can also affect children and young adults. All tauopathies share ectopic expression, mislocalization, or aggregation of the microtubule associated protein TAU, encoded by the <i>MAPT</i> gene. As TAU is a neuronal protein widely expressed in the CNS, the overwhelming majority of tauopathies are neurological disorders. They are characterized by cognitive dysfunction often leading to dementia, and are frequently accompanied by movement abnormalities such as parkinsonism. Tauopathies can lead to severe neurological deficits and premature death. For some tauopathies there is a clear genetic cause and/or an epigenetic contribution. However, for several others the disease etiology is unclear, with few tauopathies being environmentally triggered. Here, we review current knowledge of tauopathies listing known genetic and important sporadic forms of these disease. Further, we discuss how DNA methylation as a major epigenetic mechanism emerges to be involved in the disease pathophysiology of Alzheimer’s, and related genetic and non-genetic tauopathies. Finally, we debate the application of epigenetic signatures in peripheral blood samples as diagnostic tools and usages of epigenetic therapy strategies for these diseases.Geraldine Zimmer-BenschHans ZempelMDPI AGarticleAlzheimertauopathyTAU<i>MAPT</i>epigeneticsneurodegenerationBiology (General)QH301-705.5ENCells, Vol 10, Iss 3064, p 3064 (2021)
institution DOAJ
collection DOAJ
language EN
topic Alzheimer
tauopathy
TAU
<i>MAPT</i>
epigenetics
neurodegeneration
Biology (General)
QH301-705.5
spellingShingle Alzheimer
tauopathy
TAU
<i>MAPT</i>
epigenetics
neurodegeneration
Biology (General)
QH301-705.5
Geraldine Zimmer-Bensch
Hans Zempel
DNA Methylation in Genetic and Sporadic Forms of Neurodegeneration: Lessons from Alzheimer’s, Related Tauopathies and Genetic Tauopathies
description Genetic and sporadic forms of tauopathies, the most prevalent of which is Alzheimer’s Disease, are a scourge of the aging society, and in the case of genetic forms, can also affect children and young adults. All tauopathies share ectopic expression, mislocalization, or aggregation of the microtubule associated protein TAU, encoded by the <i>MAPT</i> gene. As TAU is a neuronal protein widely expressed in the CNS, the overwhelming majority of tauopathies are neurological disorders. They are characterized by cognitive dysfunction often leading to dementia, and are frequently accompanied by movement abnormalities such as parkinsonism. Tauopathies can lead to severe neurological deficits and premature death. For some tauopathies there is a clear genetic cause and/or an epigenetic contribution. However, for several others the disease etiology is unclear, with few tauopathies being environmentally triggered. Here, we review current knowledge of tauopathies listing known genetic and important sporadic forms of these disease. Further, we discuss how DNA methylation as a major epigenetic mechanism emerges to be involved in the disease pathophysiology of Alzheimer’s, and related genetic and non-genetic tauopathies. Finally, we debate the application of epigenetic signatures in peripheral blood samples as diagnostic tools and usages of epigenetic therapy strategies for these diseases.
format article
author Geraldine Zimmer-Bensch
Hans Zempel
author_facet Geraldine Zimmer-Bensch
Hans Zempel
author_sort Geraldine Zimmer-Bensch
title DNA Methylation in Genetic and Sporadic Forms of Neurodegeneration: Lessons from Alzheimer’s, Related Tauopathies and Genetic Tauopathies
title_short DNA Methylation in Genetic and Sporadic Forms of Neurodegeneration: Lessons from Alzheimer’s, Related Tauopathies and Genetic Tauopathies
title_full DNA Methylation in Genetic and Sporadic Forms of Neurodegeneration: Lessons from Alzheimer’s, Related Tauopathies and Genetic Tauopathies
title_fullStr DNA Methylation in Genetic and Sporadic Forms of Neurodegeneration: Lessons from Alzheimer’s, Related Tauopathies and Genetic Tauopathies
title_full_unstemmed DNA Methylation in Genetic and Sporadic Forms of Neurodegeneration: Lessons from Alzheimer’s, Related Tauopathies and Genetic Tauopathies
title_sort dna methylation in genetic and sporadic forms of neurodegeneration: lessons from alzheimer’s, related tauopathies and genetic tauopathies
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/d37cc600ad824f99af45406ab5a87325
work_keys_str_mv AT geraldinezimmerbensch dnamethylationingeneticandsporadicformsofneurodegenerationlessonsfromalzheimersrelatedtauopathiesandgenetictauopathies
AT hanszempel dnamethylationingeneticandsporadicformsofneurodegenerationlessonsfromalzheimersrelatedtauopathiesandgenetictauopathies
_version_ 1718412681328721920